Wissenschaftliche Publikationen

The relative risk of second primary cancers in Switzerland. Feller A, Matthes KL, Bordoni A, Bouchardy C, Buillard JL, Herrmann C, Konzelmann I, Maspoli M, Mousavi SM, Rohrmann S, Staehlin K, Arndt V, the NICER Working Group. Google Scholar.2019, Jan. https://serval.unil.ch/resource/serval:BIB_55EA56152D3B.P001/REF.pdf

Regional differences and trends in breast cancer surgical procedures and their relation to socioeconomic disparities and screening patterns. Herrmann C, Ess SM, Walser E, Frick H, Thürlimann B, Probst-Hensch N, Rothermundt C, Vounatsou P.Jounal of Public Health: From Theory to Practice. 2019, Jan. https://link.springer.com/article/10.1007/s10389-018-01007-7

Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries. Benzarti S, Daskalakis M, Feller A, Bacher VU, Schnegg-Kaufmann A, Rüfer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stussi G, Arndt V, Bonadies N, the NICER Working Group. Cancer Epidemiology. 2019, Jan. https://www.sciencedirect.com/science/article/pii/S1877782118306507?via%3Dihub

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Jegerlehner S, Chiolero A, Aujesky D, Rodondi N, Germann S, Konzelmann I, Bulliard JL, on behalf of the NICER Working Group. PLOS one. 2019 Feb. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361620/

Mastectomy rates in Switzerland. Herrmann C, Ess SM, Walser E, Frick H, Thürlimann B, Probst-Hensch N, Rothermundt C, Mousavi SM, Morant R, Vounatsou P. Poster, Mar 2019.https://www.oncoconferences.ch/programme-BCC2019

Bayesian estimates of the incidence of rare cancers in Europe. Botta L, Capocaccia R, Trama A, Herrmann C, Salméron D, De Angelis R, Mallone S, Bidoli E, Marcos-Gragera R, Dudek-Godeau D, Gatta G, Cleries R, The RARECAREnet Working group. Cancer Epidemiology. 2018 Jun. https://www.sciencedirect.com/science/article/pii/S1877782118301000?via%3Dihub

Benign and Malignant Primary Brain Tumours in the Swiss Population (2010-2014). Lorez M, Nanieva R, Arndt V, Rohrmann S, and the NICER Working Group. Schweizer Krebsbulletin. 2018, Juni. http://www.nicer.org/assets/files/publications/others/skb_02_2018_benign_and_malignant_primary_brain_tumours_ch_pop.pdf

Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies. Herrmann C, Vounatsou P, Thürlimann B, Probst-Hensch N, Rothermund C, Ess S.  BMJ Open. 2018 Mar. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857683/

Impact of subtypes and comorbidities on breast cancer relapse and survival in population-based studies. Ess S M, Herrmann C, Bouchardy C, Neyroud I, Rapiti E, Konzelmann I, Bordoni A, Ortelli L, Rohrmann S, Frick H, Mousavi M, Thürlimann B. Breast. 2018 Oct. https://www.thebreastonline.com/article/S0960-9776(18)30142-5/fulltext

Incidence and Mortality trends of Gastric Cancer in Switzerland1988-2014. Schmidt A, Fleischmann A, Lorez M, Rohrmann S, and the NICER Working Group. Schweizer Krebsbulletin. 2018 Dec. https://www.sakk.ch/sites/default/files/2018-10/SBK%204-2018_Final_0.pdf

Incidence-based Mortality Trends for Thyrioid Cancer: Is there a “true” Increase in Incidence of Thyroid Cancer in Switzerland? Dyntar D, Lorez M, Diebold J and the NICER Working Group. Schweizer Krebsbulletin. 2018 Sep. https://www.luks.ch/sites/default/files/2019-02/dr.d.dyntar_skb_2018-3_thyroid-cancer-trend-in-switzerland_incidence-based_mortality.pdf

Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis? Minicozzi P, Walsh P M, Sánchez M-J, Trama A, Innos K, Marcos-Gragera R, Dimitrova N, Botta L, Johannsen T B, Rossi S, Sant M and the EUROCARE-5 Working Group. European Journal of Cancer. 2018 Apr. https://www.ejcancer.com/article/S0959-8049(18)30118-7/fulltext

Krebs in der Ostschweiz: Räumliche Vergleiche. Walser-Domjan E, Herrmann C, Mousavi M. Riport. 2018 Frühling; 87: S. 6-7. https://www.risch.ch/wp-content/uploads/2018/02/LMZ-RP-87-web.pdf

Lung cancer and smoking trends in the young in Switzerland: a study based on data of the National Institute for Cancer Epidemiology and Registration  and of the Swiss Health Surveys. Mousavi SM, Schmid S, Cerny T, Früh M. Swiss Medical Weekly. 2018 Dec. https://smw.ch/article/doi/smw.2018.14708

Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Imbimbo M, Maury JM, Garassino M, Girard N, RARECAREnet Working Group. European Journal of Surgical Oncology. 2018 Feb. https://www.ejso.com/article/S0748-7983(18)30114-8/fulltext

Swiss cancer prevalence and language region. Lorez M. Galli F, Arndt V, and the NICER Working Group. Schweizer Krebsbulletin. 2018 Mar. http://www.nicer.org/assets/files/publications/others/skb_01_2018_swiss_cancer_prevalence_and_language_region.pdf

Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Nicolai N, Biasoni D, Catanzaro M A Colecchia M, Trama A, RARECAREnet Working Group. European Journal of Surgical Oncology. 2018 Feb. https://www.sciencedirect.com/science/article/pii/S0748798318304165

Treatment challenges in and outside a network setting: Head and neck cancers. Orlandi E, Alfieri S, Simon C, Trama A, Licitra L, RARECAREnet Working Group. European Journal of Surgical Oncology. 2018 Feb. https://www.ejso.com/article/S0748-7983(18)30417-7/fulltext

Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study. Gotta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, Comber H, Dimi 18: 1022–39 trova N, Leinonen M K, Siesling S, van der Zwan J M, Van Eycken L, Visser O, Žakelj M P, Anderson L A, Bella F, Innos K, Otter R, Stiller C A, Trama A, for the RARECAREnet working group. THE LANCET Oncology. 2017 Jul; 18: 1022–39.

Epidemiology of rare cancers and inequalities in oncologic outcomes . Gatta G, Trama A, Capocaccia R, RARECARENet Working Group. European Journal of Cancer Surgery. 2017 Sep; pii: S0748-7983(17)30685-6.

Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non‐small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices. Ess S M, Herrmann C, Frick H, Krapf M, Cerny T, Jochum W, Früh M. European Journal of Cancer Care. 2017 Nov;26(6). doi: 10.1111/ecc.12721.

Evaluation of completeness of case ascertainment in Swiss cancer registration. Lorez M, Bordoni A, Bouchardy C, Bulliard J-L, Camey B, Dehler S, Frick H, Konzelmann I, Maspoli M, Mousavi S M, Rohrmann S and Arndt V. European Journal of Cancer Prevention. 2017 Sep;26 Joining forces for better cancer registration in Europe:S139-S146.

Geographical variability in survival of European children with central nervous system tumours. Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, Sánchez MJ, Lacour B, Kaatsch P, Berrino F, Rutkowski S, Botta L; EUROCARE-5 Working Group. European Journal of Cancer. 2017 Sep Sep;82:137-148.

Multiple primary tumors: challenges and approaches, a review. Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T and Omlin A. ESMO Open. 2017 May 2;2(2):e000172.

Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study. Jegerlehner S, Bulliard J-L, Aujesky D, Rodondi N, Germann S, Konzelmann I, Chiolero A, NICER Working Group. PLOS ONE. 2017 Jun 14;12(6).

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Ray-Coquard I, Trama A L, Seckl M J, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann J A, RARECARENet Working Group. European Journal of Cancer Surgery. 2017 Nov 3. pii: S0748-7983(17)30947-2.

Treatment challenges in and outside a network setting: Soft tissue sarcomas. Pasquali S, Bonvalot S, Tzanis D, Casali P G, Trama A, Gronchi A, RARECARENet Working Group. European Journal of Cancer Surgery. 2017 Sep 19. pii: S0748-7983(17)30705-9.

Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Lykoudis P M, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai G K, 2017 Oct 16. pii: S0748-7983(17)30941-1.

Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study.Neumair P, Joos L, Warschkow R, Dutly A, Ess S, Hitz F, Früh M, Brutsche M, Baty F, Krähenbühl S, Cerny T, Joerger M. Lung Cancer. 2016 Oct;100:38-44. doi: 10.1016/j.lungcan.2016.07.027.

Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study.Neumair P, Joos L, Warschkow R, Ess S, Hitz F, Früh M, Brutsche MH, Baty F, Krähenbühl S, Jörger M.J Thorac Oncol. 2016 Apr;11(4 Suppl):S131. doi: 10.1016/S1556-0864(16)30279-9.

Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012. Bonadies N, Feller A, Rovo A, Ruefer A, Blum S, Gerber B, Stuessi G, Benz R, Cantoni N, Holbro A, Schmidt A, Lehmann T, Wilk C M, Arndt V, the NICER Working Group. Cancer Epidemiology. 2017 Feb;46:85-92.

Effects of age and stage on prostate cancer survival in Switzerland. Rohrmann, S., Bouchardy, C., Mousavi, M., Lorez, M., Arndt, V., NICER Working Group Swiss Cancer Bulletin 2016, 36(4), 354-359.

Population-based cancer registration and research in Switzerland: examples, limitations and perspectives.Arndt, V., NICER Working Group. Swiss Cancer Bulletin 2016, 36(2), 163-167

Data quality in rare cancers registration: the report of the RARECARE data quality study.Trama A, Marcos-Gragera R, Sánchez Pérez MJ, van der Zwan JM, Ardanaz E, Bouchardy C, Melchor JM, Martinez C, Capocaccia R, Vicentini M, Siesling S, Gatta G; RARECARE working group contributing to the data quality study. Tumori. 2017 Jan 21;103(1):22-32. doi: 10.5301/tj.5000559.

Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.Trama A, Botta L, Foschi R, Ferrari A, Stiller C, Desandes E, Maule MM, Merletti F, Gatta G; EUROCARE-5 Working Group. Lancet Oncol. 2016 Jul;17(7):896-906. doi: 10.1016/S1470-2045(16)00162-5.

Relatives Überleben nach Dickdarmkrebs in den Kantonen St. Gallen und Appenzell. Harald Frick, Christian Herrmann, Silvia Ess, riport Nov 2016.

Breast cancer in younger women in Switzerland 1996-2009: A longitudinal population-based study.
Bodmer A, Feller A, Bordoni A, Bouchardy C, Dehler S, Ess S, Levi F, Konzelmann I, Rapiti E, Steiner A, Clough-Gorr KM; NICER Working Group. Breast. 2015 Apr;24(2):112-7. doi: 10.1016/j.breast.2014.11.004. Epub 2014 Dec 15. 

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group.Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26. 

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R; EUROCARE-5 Working Group. Lancet Oncol. 2014 Aug;15(9):931-42. doi: 10.1016/S1470-2045(14)70282-7. Epub 2014 Jul 13. Erratum in: Lancet Oncol. 2014 Sep;15(10):417.

Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
Paul Martin Putora • Silvia Ess • Cedric Panje •Thomas Hundsberger • Karin van Leyen •
Ludwig Plasswilm • Martin Früh. Received: 7 October 2014 / Accepted: 20 January 2015 / Published online: 28 January 2015 Springer Science+Business Media Dordrecht 2015

40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland
Christian Herrmann, Silvia Ess, Beat Thürlimann, Nicole Probst-Hensch and Penelope Vounatsou
BMC Cancer201515:666, DOI: 10.1186/s12885-015-1660-8, Received: 1 December 2014, Accepted: 28 September 2015, Published: 9 October 2015

Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.
Niederer-Wüst SM, Jochum W, Förbs D, Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stoeckli SJ, Broglie MA.Surgery. 2015 Jan;157(1):119-25.. 10.1016/j.surg.2014.07.015.

Epidemiologie und Trends der Lungenkarzinome im Kanton St. Gallen</span>
Harald Frick, Christian Herrmann, Silvia Ess, Martin Früh, riport 80 Nov 2015

Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011.
Feller A1, Fehr M2, Bordoni A3, Bouchardy C4, Frick H5, Mousavi M6, Steiner A7, Arndt V8, Clough-Gorr KM9; Nicer Working Group.Swiss Med Wkly. 2015 Dec 10;145:w14245. doi: 10.4414/smw.2015.14245. eCollection 2015.

Breast cancer in younger women in Switzerland 1996-2009: A longitudinal population-based study.
Bodmer A, Feller A, Bordoni A, Bouchardy C, Dehler S, Ess S, Levi F, Konzelmann I, Rapiti E, Steiner A, Clough-Gorr KM; NICER Working Group. Breast. 2015 Apr;24(2):112-7. doi: 10.1016/j.breast.2014.11.004. Epub 2014 Dec 15. 

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26. 

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.
Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V; RARECARE Working Group. Cancer Epidemiol. 2014 Dec;38(6):670-8. doi: 10.1016/j.canep.2014.09.009. Epub 2014 Oct 22. 

Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R; EUROCARE-5 Working Group. Lancet Oncol. 2014 Aug;15(9):931-42. doi: 10.1016/S1470-2045(14)70282-7. Epub 2014 Jul 13. Erratum in: Lancet Oncol. 2014 Sep;15(10):417. 

A Bayesian generalized age-period-cohort power model for cancer projections. 
Jürgens V, Ess S, Cerny T, Vounatsou P. Stat Med. 2014 Nov 20;33(26):4627-36. doi: 10.1002/sim.6248. Epub 2014 Jul 3. 

Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis.
Diem S, Ess S, Cerny T, Früh M, Hitz F. Eur J Intern Med. 2014 Jul;25(6):577-82. doi: 10.1016/j.ejim.2014.05.001. Epub 2014 May 28. 

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.
Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U. Hematol Oncol. 2014 Dec;32(4):192-6. doi: 10.1002/hon.2123. Epub 2013 Dec 11.

Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R; EUROCARE Working Group. Lancet Oncol. 2014 Jan;15(1):35-47. doi: 10.1016/S1470-2045(13)70548-5. Epub 2013 Dec 5. Erratum in: Lancet Oncol. 2014 Feb;15(2):e52. 

Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, Trama A, Visser O, Brenner H, Ardanaz E, Bielska-Lasota M, Engholm G, Nennecke A, Siesling S, Berrino F, Capocaccia R; EUROCARE-5 Working Group. Lancet Oncol. 2014 Jan;15(1):23-34. doi: 10.1016/S1470-2045(13)70546-1. Epub 2013 Dec 5.

Cancer survivors in Switzerland: a rapidly growing population to care for.
Herrmann C1, Cerny T, Savidan A, Vounatsou P, Konzelmann I, Bouchardy C, Frick H, Ess S.
BMC Cancer. 2013 Jun 14;13:287. doi: 10.1186/1471-2407-13-287.

Outcome of mantle cell lymphoma patients treated at a single institution over the past decade.
Hitz F, Diem S, Haile SR, Ess S, Cerny T, Mey U. 
Hematol Oncol. 2013 Dec 11. doi: 10.1002/hon.2123. [Epub ahead of print]

Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study.
Bertisch B, Franceschi S, Lise M, Vernazza P, Keiser O, Schöni-Affolter F, Bouchardy C, Dehler S, Levi F, Jundt G, Ess S, Pawlita M, Kovari H, Wandeler G, Calmy A, Cavassini M, Stöckle M, Clifford G; Swiss HIV Cohort Study Investigators. 
Am J Epidemiol. 2013 Sep 15;178(6):877-84. doi: 10.1093/aje/kwt153. Epub 2013 Jul 30. 

Tobacco-related cancer mortality: projections for different geographical regions in Switzerland.
Jürgens V, Ess S, Phuleria HC, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. 
Swiss Med Wkly. 2013 Jun 25;143:w13771. doi: 10.4414/smw.2013.13771. 

Cancer survivors in Switzerland: a rapidly growing population to care for.
Herrmann C, Cerny T, Savidan A, Vounatsou P, Konzelmann I, Bouchardy C, Frick H, Ess S. 
BMC Cancer. 2013 Jun 14;13:287. doi: 10.1186/1471-2407-13-287. PubMed Central PMCID: PMC3685597.

Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland.
Jürgens V, Ess S, Phuleria HC, Früh M, Schwenkglenks M, Frick H, Cerny T, Vounatsou P. 
Geospat Health. 2013 May;7(2):219-36. 

Management of elderly patients with advanced non-small cell lung cancer: a single-center experience.
Früh M, Besrour H, Gillessen S, Joerger M, Hitz F, Savidan A, Cerny T, Ess S. 
Chemotherapy. 2013; 59(1):42-50. doi: 10.1159/000350498. Epub 2013 Jul 2. 

Treatment of breast cancer in the elderly: a prospective, population-based Swiss study.
Joerger M, Thürlimann B, Savidan A, Frick H, Rageth C, Lütolf U, Vlastos G, Bouchardy C, Konzelmann I, Bordoni A, Probst-Hensch N, Jundt G, Ess S. 
J Geriatr Oncol. 2013 Jan;4(1):39-47. doi: 10.1016/j.jgo.2012.08.002. Epub 2012 Aug 24. 

Working Group Trends in Bladder Cancer Survival in Switzerland
Bouchardy C, Lorez M, Clough-Gorr K, and the NICER 
Schweizer Krebsbulletin Nr 2/2013

Working Group Trends in Prostate Cancer Survival in Switzerland
Dehler S, Rohrmann S, Lorez M, Clough-Gorr K, and the NICER 
Schweizer Krebsbulletin Nr 1/2013

Working Group Trends in Stomach Cancer Survival in Switzerland
Spitale A, Feller A, Lorez M, and the NICER 
Schweizer Krebsbulletin Nr 3/2013

A population based study on the implementation of treatment recommendations for chemotherapy in early breast cancer. 
Jörger M., Thürlimann B., Savidan A, T, Frick H, Bouchardy C, Konzelmann I, Probst-Hensch N, Ess S. 
Clinical Breast Cancer, Vol 12, No. 2, 102-9. 2012

A population based study on the patterns of use of different chemotherapy regimens in patients with early breast cancer.
Jörger M, Ess S, Dehler S, Savidan A, Bouchardy C, Frick H, Konzelmann I, Thürlimann B. 
Swiss Med Wkly. 2012; 142:w13571 Published 11 April 2012

Treatment of breast cancer in the elderly: A prospective, population–based Swiss study.
Jörger M,, Thürlimann B., Savidan A, T, Frick H, Rageth C, Lütolf U, Vlastos G, Bouchardy C, Konzelmann I, Bordoni A, Probst-Hentsch N,Jundt G, Ess S.
J Geriatr Oncol (2012)

Extra pulmonary small cell carcinoma: An indication for prophylactic cranial irradiation? A single center experience.
Früh M, Kacsir B, Ess S, Cerny T, Rodriguez R, Plasswilm L. 
Strahlenther Onkol 2011 Sept; 187(9): 561-7 Epub 2011 Jun 27

Surgical treatment of early stage breast cancer in the elderly: an international comparison.
Kiderlen M, Bastiaannet E, Walsh P. M, Keating N. L, .Schrod S, Engel J, van de Water W, Ess S M, van Eycken L, Miranda A, de Munck L, van de Velde C, de Craen A. J. M, Liefers G. J. 
Breast Cancer Res Treat 2012 Apr, 132(2);675-82Epub 2011 Nov 27 

Rare cancers are not so rare: the rare cancer burden in Europe.
Gatta G, van der Zwan JM, Casali PG Siesling S, DeiTos AP Kunkler I, Otter R, Licitra L, Mallone S, Tavilla A, Trama A, Capocaccia R; RARECARE Working Group 
Eur J.Cancer 2011 Nove; 47(17):2493-511. Epub 2011 Oct 25

Survival of European Patients with central nervous system tumors.
Sant M, Minicozzi P, Lagorio S, Boerge Johannesen T, Marcos-Gragera R, Francisi S, EUROCARE Working Group 
Int J Cancer 2012 Jul 1, 131(1):173-85 Epub 2011 Nov 10

Predictors of state-of-the-art management of early breast cancer in Switzerland.
Ess S, Joerger M, Frick H, Savidan A, et al.
Ann Oncol 2011 Mar,22(3):618-24 Epub 2010 Aug 12. 

Premature deaths in Switzerland 1995-2006: causes and trends.
Savidan A, Junker C, Cerny T, Ess S.
Swiss Med Wkly 2010 Aug 24 140:w13077. doi: 10.4414/smw.2010.13077

Geographic variation in breast cancer care in Switzerland.
Ess S, Savidan A, Frick H et al.
Cancer Epidemiology 2010; 34(2): 116-121.

Impact of obesity on diagnosis and treatment of breast cancer.
Deglise C, Bouchardy C, Burri M, Usel M, Neyroud-Caspar I, Vlastos G, Chappuis PO, Ceschi M, Ess S, Castiglione M, Rapiti E, Verkooijen HM.
Breast Cancer Research Treat 2010; 120(1): 185-93

Changing patterns of cancer incidence in the early and late HAART periods: the Swiss HIV Cohort Study.
Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, Bouchardy C, Dehler S, Jundt G, Ess S, Bordoni A, Konzelmann I, Frick H, Dal Maso L, Elzi L, Furrer H, Calmy A, Cavassini M, Ledergerber B, Keiser O; Swiss HIV Cohort Study.
Br J Cancer. 2010 Jul 27;103(3):416-22. Epub 2010 Jun 29.

Manual for coding and reporting haematological malignancies.
HAEMACARE Working Group
Tumori 2010 Jul-Aug; 96(4): i-A32

The burden of rare cancers in Europe.
Gatta G, Capocaccia R, Trama A, Martínez-García C; RARECARE Working Group. (S. Ess as member of the RARECARE Working Group)
Adv Exp Med Biol. 2010;686:285-303. Review.

Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study.
Zigon G, Berrino F, Gatta G, Sánchez MJ, van Dijk B, Van Eycken E, Francisci S; EUROCARE Working Group
Ann Oncol 2011 Jan; 22(1): 165-74 Epub 2010 Jun 29

Lung cancer in the Canton of St. Gallen, Eastern Switzerland: sex-associated differences in smoking habits, disease presentation and survival.
Cerny D, Cerny T, Ess S, D'Addario G, Früh M.
Onkologie. 2009 Oct;32(10):569-73. Epub 2009 Sep 14.

Life tables for world-wide comparison of relative survival for cancer.
Baili P, Micheli A, De Angelis R, Weir HK, Francisci S, Santaquilani M, Hakulinen T, Quaresmas M, Coleman MP; CONCORD Working Group.
Tumori. 2008; 94(5): 658-68

Cancer survival in five continents: a worldwide population-based study.
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, Micheli A, Sant M, Weir HK, Elwood JM, Tsukuma H, Koifman S, E Silva GA, Francisci S, Santaquilani M, Verdecchia A, Storm HH, Young JL; CONCORD Working Group.
Lancet Oncol. 2008 Aug; 9(8): 730-56

Hodgkin lymphoma in the Swiss HIV Cohort Study.
Clifford GM, Rickenbach M, Lise M, Dal Maso L, Battegay M, Bohlius J, Boffi El Amari E, Karrer U, Jundt G, Bordoni A, Ess S, Franceschi S; Swiss HIV Cohort Study. 
Blood. 2009 Jun 4;113(23):5737-42. Epub 2009 Mar 31

Left-sided excess in the laterality of cutaneous melanoma.
Bulliard JL, Ess S, Bordoni A, Konzelmann I, Levi F.
Arch Dermatol. 2008 Apr;144(4):556-8.

Prevalence and direct medical costs of end-stage renal disease in patients with type 2 diabetes mellitus in Switzerland for 2001.
Sandoz MS, Ess SM, Keusch GW, Schwenkglenks M, Szucs TD
Swiss Med Wkly. 2004 Aug 7;134(31-32):448- 58.

Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland.
Ess SM, Schaad UB, Gervaix A, Pinösch S, Szucs TD
Vaccine. 2003 Jul 4;21(23):3273-81.

High dose lisinopril in heart failure: economic considerations.
Ess SM, Lüscher TF, Szucs TD
Cardiovasc Drugs Ther. 2002 Jul;16(4):365-71.

European healthcare policies for controlling drug expenditure.
Ess SM, Schneeweiss S, Szucs TD
Pharmacoeconomics. 2003;21(2):89-103.

Economic evaluation of immunization strategies.
Ess SM, Szucs TD
Clin Infect Dis. 2002 Aug 1;35(3):294-7. Epub 2002 Jul 10. Review.